Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The comparison between nicotinamide and sevelamer aims to demonstrate, in chronic
hemodialysed patients, the non-inferiority of nicotinamide in terms of control of the
phosphatemia. Secondary objectives is to compare the two treatments in terms of efficiency in
other biological parameters, vascular calcification and bone mass loss and on the clinical
and biological tolerance and finally to explore the roles of metabolites of nicotinamide.